Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer

pharmafocusasiaApril 19, 2019

Tag: sk biopharmaceuticals , lung cancer , twoXAR

PharmaSources Customer Service